Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Ferrara

Showing results (1-10 of 143) with videos related to

Pageof 15
Sort By:
Physical Review Letters|December 30, 2017
Private States, Quantum Data Hiding, and the Swapping of Perfect SecrecyMatthias Christandl, Roberto Ferrara
The Journal of Experimental Medicine|October 10, 2022
Eating away T cell responses in lung cancerRoberto Ferrara, Luca Roz
Future Oncology (London, England)|July 21, 2020
Atypical patterns of response and progression in the era of immunotherapy combinationsRoberto Ferrara, Ignacio Matos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers-LetterRoberto Ferrara, Sandrine Susini, Aurelien Marabelle
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin Besse
JAMA Oncology|March 22, 2019
Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In ReplyRoberto Ferrara, Caroline Caramella, Benjamin Besse
Entropy (Basel, Switzerland)|December 8, 2020
Performance Analysis of Identification CodesSencer Derebeyoğlu, Christian Deppe, Roberto Ferrara
Physical Review Letters|May 7, 2021
Upper Bounds on Device-Independent Quantum Key DistributionMatthias Christandl, Roberto Ferrara, Karol Horodecki
JAMA Oncology|November 19, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-ReplyCaroline Caramella, Roberto Ferrara, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
PD-L1-Overexpressing NSCLC: Overcoming All-Comer Approach and Network Effect to Weather the "Winter" of Cancer ImmunotherapyFabio Salomone, Antonio Nuccio, Roberto Ferrara
Pageof 15

Showing results (1-10 of 143) with videos related to

Sort By:
Pageof 15
Physical Review Letters|December 30, 2017
Private States, Quantum Data Hiding, and the Swapping of Perfect SecrecyMatthias Christandl, Roberto Ferrara
The Journal of Experimental Medicine|October 10, 2022
Eating away T cell responses in lung cancerRoberto Ferrara, Luca Roz
Future Oncology (London, England)|July 21, 2020
Atypical patterns of response and progression in the era of immunotherapy combinationsRoberto Ferrara, Ignacio Matos
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human Cancers-LetterRoberto Ferrara, Sandrine Susini, Aurelien Marabelle
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 15, 2018
Progress in the Management of Advanced Thoracic Malignancies in 2017Roberto Ferrara, Laura Mezquita, Benjamin Besse
JAMA Oncology|March 22, 2019
Hyperprogression-Immunotherapy-Related Phenomenon vs Intrinsic Natural History of Cancer-In ReplyRoberto Ferrara, Caroline Caramella, Benjamin Besse
Entropy (Basel, Switzerland)|December 8, 2020
Performance Analysis of Identification CodesSencer Derebeyoğlu, Christian Deppe, Roberto Ferrara
Physical Review Letters|May 7, 2021
Upper Bounds on Device-Independent Quantum Key DistributionMatthias Christandl, Roberto Ferrara, Karol Horodecki
JAMA Oncology|November 19, 2020
Clarification of Definitions of Hyperprogressive Disease During Immunotherapy-ReplyCaroline Caramella, Roberto Ferrara, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 5, 2025
PD-L1-Overexpressing NSCLC: Overcoming All-Comer Approach and Network Effect to Weather the "Winter" of Cancer ImmunotherapyFabio Salomone, Antonio Nuccio, Roberto Ferrara
Pageof 15